I quit recommending stocks via blog posts a long time ago, and those past stock recommendation posts never gave all that much information on why I liked the stock. By now I feel a little more confident in my recommendations, at least when they are about old favourites of mine that I have followed for a few years. Well, there is one stock that I kept recommending implicitly via my mostly virtual fund thing and via twitter posts, but have never made the topic of any of my blog posts. MorphoSys (MOR:GR, MPSYF). The good news has kept up with the increasing share price, so I think it is still a good time to buy a few shares. If you plan on doing so please do it via the Xetra or Frankfurt stock exchange (if your transaction fees for those exchanges is not too high) or use the U.S. exchange (MPSYF) with tight limits placed close to the, at the time, current German share price (converted to USD). MPSYF has VERY low trading volume. As I mentioned on twitter I no longer recommend buying or holding Algeta shares, by the way. They had been another one of my long term favourite stocks that I have mentioned quite a few times here and on twitter.
A recent MorphoSys presentation is here.